CompoSecure (CMPO) Financials

$13.22 +0.53 (+4.18%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$13.02 -0.21 (-1.55%)

As of 05/23/2025 07:58 PM Eastern

Annual Income Statements for CompoSecure

This table shows CompoSecure's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Income / (Loss) Attributable to Common Shareholders	-54	19	19	3.15	78	81
Consolidated Net Income / (Loss)	-83	113	132	83	78	81
Net Income / (Loss) Continuing Operations	-83	113	132	83	78	81
Total Pre-Tax Income	-81	117	136	83	78	81
Total Operating Income	108	119	115	81	84	87
Total Gross Profit	219	209	220	145	133	128
Total Revenue	421	391	378	268	261	243
Operating Revenue	421	391	378	268	261	243
Total Cost of Revenue	201	182	159	123	128	115
Operating Cost of Revenue	201	182	159	123	128	115
Total Operating Expenses	112	90	105	63	49	41
Selling, General & Admin Expense	112	90	105	63	49	41
Total Other Income / (Expense), net	-189	-2.01	21	1.13	-6.14	-5.45
Interest Expense	20	28	21	-	-	-
Interest & Investment Income	4.65	4.98	1.25	-10	-5.27	-4.75
Other Income / (Expense), net	-173	21	41	11	-0.88	-0.70
Income Tax Expense	2.19	4.56	4.36	-0.86	0.00	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-29	93	113	80	0.00	0.00
Basic Earnings per Share	($1.22)	$1.03	$1.21	$0.21	$0.00	$0.00
Weighted Average Basic Shares Outstanding	44.01M	18.66M	15.37M	14.93M	0.00	0.00
Diluted Earnings per Share	($1.22)	$0.96	$1.13	$0.12	$0.00	$0.00
Weighted Average Diluted Shares Outstanding	44.01M	35.31M	32.56M	94.57M	0.00	0.00
Weighted Average Basic & Diluted Shares Outstanding	102.31M	80.53M	77.88M	76.07M	-	-

This table shows CompoSecure's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-27	-42	11	4.03	3.70	7.48	5.74	2.33	3.97	2.82
Consolidated Net Income / (Loss)	-48	-85	34	17	31	38	33	11	22	22
Net Income / (Loss) Continuing Operations	-48	-85	34	17	31	38	33	11	22	22
Total Pre-Tax Income	-46	-85	34	16	35	39	34	9.47	23	22
Total Operating Income	16	29	32	31	31	29	30	29	25	26
Total Gross Profit	53	55	56	55	53	49	54	53	50	62
Total Revenue	101	107	109	104	100	97	99	95	94	103
Operating Revenue	101	107	109	104	100	97	99	95	94	103
Total Cost of Revenue	48	52	52	49	47	48	45	42	44	42
Operating Cost of Revenue	48	52	52	49	47	48	45	42	44	42
Total Operating Expenses	37	26	24	24	22	20	24	24	25	36
Selling, General & Admin Expense	37	26	24	24	22	20	24	24	25	36
Total Other Income / (Expense), net	-62	-114	2.06	-15	4.40	10	3.33	-20	-1.69	-3.36
Interest & Investment Income	21	-5.14	-5.32	-5.42	22	-5.70	-5.44	-5.93	16	-5.30
Other Income / (Expense), net	-62	-109	7.38	-9.48	9.88	16	8.77	-14	3.90	1.94
Income Tax Expense	2.14	0.63	0.26	-0.84	3.90	0.95	0.97	-1.26	0.62	0.39
Net Income / (Loss) Attributable to Noncontrolling Interest	-22	-43	22	13	27	31	27	8.41	18	19
Basic Earnings per Share	($0.76)	($1.10)	$0.44	$0.20	$0.20	$0.39	$0.31	$0.13	$0.24	$0.18
Weighted Average Basic Shares Outstanding	44.01M	38.21M	25.44M	20.57M	18.66M	19.07M	18.54M	17.63M	15.37M	15.43M
Diluted Earnings per Share	($0.61)	($1.10)	$0.32	$0.17	$0.22	$0.34	$0.29	$0.11	$0.20	$0.18
Weighted Average Diluted Shares Outstanding	44.01M	38.21M	96.64M	96.24M	35.31M	35.76M	35.53M	94.74M	32.56M	19.66M
Weighted Average Basic & Diluted Shares Outstanding	102.31M	88.13M	81.91M	80.59M	80.53M	79.32M	79.00M	78.39M	77.88M	76.35M

This table details how cash moves in and out of CompoSecure's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Change in Cash & Equivalents	36	28	-8.30	8.52	-13	14
Net Cash From Operating Activities	130	104	93	78	87	81
Net Cash From Continuing Operating Activities	130	104	93	78	87	81
Net Income / (Loss) Continuing Operations	-83	113	132	83	78	81
Consolidated Net Income / (Loss)	-83	113	132	83	78	81
Depreciation Expense	9.17	8.39	8.58	10	9.92	8.61
Amortization Expense	1.16	1.55	2.35	1.65	0.84	0.67
Non-Cash Adjustments To Reconcile Net Income	193	-5.77	-29	3.23	3.01	1.21
Changes in Operating Assets and Liabilities, net	9.48	-12	-21	-21	-4.52	-11
Net Cash From Investing Activities	-9.95	-11	-9.05	-4.75	-7.50	-9.64
Net Cash From Continuing Investing Activities	-9.95	-11	-9.05	-4.75	-7.50	-9.64
Purchase of Property, Plant & Equipment	-8.45	-11	-9.05	-4.75	-7.50	-9.64
Other Investing Activities, net	-1.50	0.00	0.00	-	-	-
Net Cash From Financing Activities	-83	-66	-92	-65	-93	-58
Net Cash From Continuing Financing Activities	-83	-66	-92	-65	-93	-58
Repayment of Debt	-15	-23	-32	-247	-14	-30
Payment of Dividends	-59	-38	-36	-241	-217	-104
Issuance of Common Equity	5.00	1.20	0.08	61	0.00	0.00
Other Financing Activities, net	-14	-5.56	-24	-15	0.00	0.00
Cash Interest Paid	21	27	21	10	5.32	4.89
Cash Income Taxes Paid	4.82	2.76	0.86	0.00	-	-

This table details how cash moves in and out of CompoSecure's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	25	17	-20	14	17	1.20	0.05	8.92	-1.79	2.04
Net Cash From Operating Activities	35	28	32	34	26	25	28	25	11	31
Net Cash From Continuing Operating Activities	35	28	32	34	26	25	28	25	11	31
Net Income / (Loss) Continuing Operations	-48	-85	34	17	31	38	33	11	22	22
Consolidated Net Income / (Loss)	-48	-85	34	17	31	38	33	11	22	22
Depreciation Expense	2.24	2.33	2.38	2.22	2.14	2.08	2.13	2.04	2.00	2.01
Amortization Expense	0.20	0.29	0.32	0.35	0.28	0.56	0.14	0.56	0.55	0.55
Non-Cash Adjustments To Reconcile Net Income	102	80	-1.01	12	-17	-1.03	-2.81	15	-21	5.13
Changes in Operating Assets and Liabilities, net	-20	31	-3.04	2.02	10	-15	-4.08	-3.93	6.51	0.99
Net Cash From Investing Activities	-4.43	-1.98	-1.91	-1.61	-4.28	-0.97	-2.03	-3.67	-1.83	-3.72
Net Cash From Continuing Investing Activities	-4.43	-1.98	-1.91	-1.61	-4.28	-0.97	-2.03	-3.67	-1.83	-3.72
Purchase of Property, Plant & Equipment	-2.93	-1.98	-1.91	-1.61	-4.28	-0.97	-2.03	-3.67	-1.83	-3.72
Net Cash From Financing Activities	-6.20	-8.87	-50	-18	-4.76	-23	-26	-12	-11	-25
Net Cash From Continuing Financing Activities	-6.20	-8.87	-50	-18	-4.76	-23	-26	-12	-11	-25
Repayment of Debt	-2.70	-2.85	-4.69	-4.69	-4.69	-13	-4.69	-0.33	-10	-5.00
Issuance of Common Equity	2.10	2.67	0.11	0.11	0.17	0.64	0.24	0.15	0.08	0.00
Other Financing Activities, net	-5.60	16	-21	-3.48	-0.24	-0.64	-2.27	-2.41	-0.11	-
Cash Interest Paid	3.62	4.10	8.72	4.18	8.95	4.67	9.06	4.57	6.44	5.30

This table presents CompoSecure's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Total Assets	474	201	163	131	81
Total Current Assets	174	139	97	78	53
Cash & Equivalents	77	41	14	22	13
Accounts Receivable	47	40	37	28	8.79
Inventories, net	45	53	42	26	30
Prepaid Expenses	4.16	5.13	3.82	2.60	1.08
Plant, Property, & Equipment, net	23	25	23	22	28
Total Noncurrent Assets	277	36	43	31	0.01
Noncurrent Deferred & Refundable Income Taxes	265	24	26	26	0.00
Other Noncurrent Operating Assets	12	13	18	5.26	0.01
Total Liabilities & Shareholders' Equity	474	201	163	131	81
Total Liabilities	617	407	455	539	274
Total Current Liabilities	76	41	47	61	42
Short-Term Debt	11	10	14	13	24
Accounts Payable	12	5.19	7.13	7.06	2.42
Accrued Expenses	15	12	10	10	12
Current Deferred & Payable Income Tax Liabilities	5.17	1.43	2.37	-	-
Other Current Liabilities	34	12	13	31	3.64
Total Noncurrent Liabilities	541	366	408	478	232
Long-Term Debt	184	326	344	375	232
Capital Lease Obligations	3.89	6.22	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	249	24	24	-	-
Other Noncurrent Operating Liabilities	104	9.51	39	103	0.41
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.00	597	600	608	0.00
Total Equity & Noncontrolling Interests	-143	-802	-892	-1,016	-193
Total Preferred & Common Equity	-143	-802	-892	-1,016	-193
Preferred Stock	0.00	0.00	0.00	0.00	-
Total Common Equity	-143	-802	-892	-1,016	-193
Common Stock	361	39	24	12	6.15
Retained Earnings	-507	-847	-925	-1,028	-199
Accumulated Other Comprehensive Income / (Loss)	2.54	4.99	8.28	0.00	-

This table presents CompoSecure's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	435	213	214	195	181	186	170
Total Current Assets	157	136	151	128	112	117	103
Cash & Equivalents	53	35	55	24	23	23	15
Accounts Receivable	44	40	35	49	37	39	46
Inventories, net	55	58	55	52	49	51	39
Prepaid Expenses	5.25	3.93	5.25	3.91	4.10	4.20	2.82
Plant, Property, & Equipment, net	23	24	25	23	24	24	23
Total Noncurrent Assets	256	53	38	44	45	44	44
Noncurrent Deferred & Refundable Income Taxes	245	41	26	28	28	28	25
Other Noncurrent Operating Assets	10	12	13	16	17	16	19
Total Liabilities & Shareholders' Equity	435	213	214	195	181	186	170
Total Liabilities	720	422	411	434	453	477	495
Total Current Liabilities	65	49	42	53	51	59	67
Short-Term Debt	10	13	12	10	19	19	9.69
Accounts Payable	9.69	9.43	4.75	14	6.64	15	13
Accrued Expenses	13	12	13	14	11	12	20
Current Deferred & Payable Income Tax Liabilities	0.12	1.43	1.43	1.67	1.67	2.37	-
Other Current Liabilities	31	13	11	13	13	10	24
Total Noncurrent Liabilities	656	373	369	381	402	418	428
Long-Term Debt	316	314	320	331	335	339	358
Noncurrent Deferred & Payable Income Tax Liabilities	234	43	24	24	24	25	-
Other Noncurrent Operating Liabilities	105	16	24	27	43	53	70
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.00	516	597	597	597	597	603
Total Equity & Noncontrolling Interests	-285	-726	-794	-835	-868	-888	-928
Total Preferred & Common Equity	-285	-726	-794	-835	-868	-888	-928
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-285	-726	-794	-835	-868	-888	-928
Common Stock	180	36	41	35	30	26	21
Retained Earnings	-468	-767	-840	-878	-907	-920	-958
Accumulated Other Comprehensive Income / (Loss)	2.57	4.85	5.44	7.65	7.91	6.63	9.00

This table displays calculated financial ratios and metrics derived from CompoSecure's official financial filings.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Growth Metrics	-	-	-	-	-	-
Revenue Growth	7.67%	3.21%	41.25%	2.83%	7.11%	0.00%
EBITDA Growth	-136.76%	-10.56%	59.45%	11.76%	-1.74%	0.00%
EBIT Growth	-146.77%	-10.67%	68.45%	11.69%	-3.65%	0.00%
NOPAT Growth	-34.18%	2.91%	35.18%	-2.01%	-3.41%	0.00%
Net Income Growth	-173.91%	-14.64%	58.03%	7.20%	-4.49%	0.00%
EPS Growth	-227.08%	-15.04%	841.67%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	24.20%	12.43%	19.29%	-10.66%	7.24%	0.00%
Free Cash Flow Firm Growth	170.63%	323.34%	-90.36%	411.78%	0.00%	0.00%
Invested Capital Growth	-122.34%	82.80%	224.46%	-184.28%	0.00%	0.00%
Revenue Q/Q Growth	0.23%	1.59%	5.14%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	-271.87%	8.35%	4.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	-401.32%	9.10%	4.68%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	102.78%	2.16%	14.56%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	-2,100.05%	8.35%	1.80%	0.00%	0.00%	0.00%
EPS Q/Q Growth	-212.82%	2.13%	7.62%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	7.45%	17.60%	-16.93%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	107.35%	16.56%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-88.97%	22.36%	92.57%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	52.13%	53.52%	58.03%	54.06%	50.90%	52.56%
EBITDA Margin	-13.07%	38.29%	44.18%	39.14%	36.01%	39.25%
Operating Margin	25.59%	30.49%	30.36%	30.39%	32.22%	35.73%
EBIT Margin	-15.53%	35.74%	41.30%	34.63%	31.88%	35.44%
Profit (Net Income) Margin	-19.77%	28.80%	34.83%	31.13%	29.86%	33.49%
Tax Burden Percent	102.70%	96.11%	96.80%	101.04%	100.00%	100.00%
Interest Burden Percent	124.01%	83.85%	87.12%	88.97%	93.66%	94.49%
Effective Tax Rate	0.00%	3.89%	3.20%	-1.04%	0.00%	0.00%
Return on Invested Capital (ROIC)	202.71%	154.60%	2,161.43%	2,097.13%	336.43%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	127.87%	154.00%	2,167.23%	2,097.50%	331.36%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-155.09%	-199.81%	-2,199.11%	-2,124.92%	-417.25%	0.00%
Return on Equity (ROE)	47.63%	-45.21%	-37.68%	-27.80%	-80.82%	0.00%
Cash Return on Invested Capital (CROIC)	0.00%	96.04%	32.08%	0.00%	136.43%	0.00%
Operating Return on Assets (OROA)	-19.35%	76.72%	106.22%	87.25%	102.12%	0.00%
Return on Assets (ROA)	-24.64%	61.83%	89.58%	78.43%	95.65%	0.00%
Return on Common Equity (ROCE)	128.99%	-153.91%	-102.77%	-55.97%	-80.82%	0.00%
Return on Equity Simple (ROE_SIMPLE)	57.97%	-14.02%	-14.77%	-8.21%	-40.41%	0.00%
Net Operating Profit after Tax (NOPAT)	75	114	111	82	84	87
NOPAT Margin	17.91%	29.30%	29.39%	30.70%	32.22%	35.73%
Net Nonoperating Expense Percent (NNEP)	74.84%	0.60%	-5.80%	-0.38%	5.07%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	134.33%	-24.90%	-20.82%	-	-	-
Cost of Revenue to Revenue	47.87%	46.48%	41.97%	45.94%	49.10%	47.44%
SG&A Expenses to Revenue	26.54%	23.04%	27.68%	23.67%	18.68%	16.83%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	26.54%	23.04%	27.68%	23.67%	18.68%	16.83%
Earnings before Interest and Taxes (EBIT)	-65	140	156	93	83	86
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-55	150	167	105	94	96
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.55	0.83	0.75	0.85	1.07	0.90
Price to Earnings (P/E)	0.00	16.90	15.25	71.94	3.59	2.70
Dividend Yield	2.46%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	5.92%	6.56%	1.39%	27.85%	37.03%
Enterprise Value to Invested Capital (EV/IC)	0.00	12.78	23.48	0.00	10.46	0.00
Enterprise Value to Revenue (EV/Rev)	2.84	3.13	3.25	4.48	2.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	8.18	7.35	11.45	5.56	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	8.76	7.86	12.94	6.28	0.00
Enterprise Value to NOPAT (EV/NOPAT)	15.88	10.69	11.05	14.60	6.22	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	9.23	11.73	13.25	15.44	5.99	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	6.22	17.20	73.19	6.89	15.33	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	-1.39	-1.67	-1.23	-0.95	-1.33	0.00
Long-Term Debt to Equity	-1.31	-1.62	-1.18	-0.92	-1.20	0.00
Financial Leverage	-1.21	-1.30	-1.01	-1.01	-1.26	0.00
Leverage Ratio	-1.93	-0.73	-0.42	-0.35	-0.42	0.00
Compound Leverage Factor	-2.40	-0.61	-0.37	-0.32	-0.40	0.00
Debt to Total Capital	355.78%	250.28%	542.43%	-1,925.99%	404.03%	0.00%
Short-Term Debt to Total Capital	20.06%	7.53%	21.78%	-62.12%	37.89%	0.00%
Long-Term Debt to Total Capital	335.72%	242.75%	520.66%	-1,863.87%	366.14%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	435.71%	909.47%	-3,023.26%	0.00%	0.00%
Common Equity to Total Capital	-255.78%	-585.99%	-1,351.91%	5,049.26%	-304.03%	0.00%
Debt to EBITDA	-3.63	2.29	2.14	3.70	2.73	0.00
Net Debt to EBITDA	-2.22	2.02	2.06	3.49	2.58	0.00
Long-Term Debt to EBITDA	-3.43	2.22	2.05	3.58	2.47	0.00
Debt to NOPAT	2.65	2.99	3.22	4.71	3.05	0.00
Net Debt to NOPAT	1.62	2.63	3.10	4.44	2.89	0.00
Long-Term Debt to NOPAT	2.50	2.90	3.09	4.56	2.76	0.00
Altman Z-Score	0.23	-0.60	-1.71	-6.17	3.94	0.00
Noncontrolling Interest Sharing Ratio	-170.83%	-240.44%	-172.74%	-101.35%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	2.28	3.40	2.05	1.29	1.29	0.00
Quick Ratio	1.64	1.99	1.08	0.82	0.53	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	192	71	17	174	34	0.00
Operating Cash Flow to CapEx	1,534.08%	953.14%	1,024.89%	1,638.85%	1,160.67%	842.00%
Free Cash Flow to Firm to Interest Expense	9.47	2.58	0.79	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	6.37	3.79	4.34	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	5.96	3.39	3.92	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	1.25	2.15	2.57	2.52	3.20	0.00
Accounts Receivable Turnover	9.57	10.05	11.61	14.60	29.64	0.00
Inventory Turnover	4.14	3.83	4.66	4.40	4.24	0.00
Fixed Asset Turnover	17.29	16.32	16.88	10.71	9.35	0.00
Accounts Payable Turnover	24.06	29.47	22.39	25.97	52.85	0.00
Days Sales Outstanding (DSO)	38.16	36.33	31.44	25.01	12.31	0.00
Days Inventory Outstanding (DIO)	88.26	95.41	78.34	83.03	86.14	0.00
Days Payable Outstanding (DPO)	15.17	12.38	16.30	14.05	6.91	0.00
Cash Conversion Cycle (CCC)	111.25	119.36	93.48	93.98	91.55	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	-21	96	52	-42	50	0.00
Invested Capital Turnover	11.32	5.28	73.55	68.30	10.44	0.00
Increase / (Decrease) in Invested Capital	-117	43	94	-92	50	0.00
Enterprise Value (EV)	1,196	1,223	1,229	1,201	522	0.00
Market Capitalization	1,074	325	285	227	279	220
Book Value per Share	($1.63)	($10.12)	($11.69)	($35.10)	($6.65)	$0.00
Tangible Book Value per Share	($1.63)	($10.12)	($11.69)	($35.10)	($6.65)	$0.00
Total Capital	56	137	66	-20	63	0.00
Total Debt	200	343	358	388	256	0.00
Total Long-Term Debt	188	332	344	375	232	0.00
Net Debt	122	301	344	366	242	0.00
Capital Expenditures (CapEx)	8.45	11	9.05	4.75	7.50	9.64
Debt-free, Cash-free Net Working Capital (DFCFNWC)	31	68	50	8.31	22	0.00
Debt-free Net Working Capital (DFNWC)	109	109	64	30	36	0.00
Net Working Capital (NWC)	98	98	50	18	12	0.00
Net Nonoperating Expense (NNE)	158	1.93	-21	-1.14	6.14	5.45
Net Nonoperating Obligations (NNO)	122	301	344	366	242	0.00
Total Depreciation and Amortization (D&A)	10	9.93	11	12	11	9.28
Debt-free, Cash-free Net Working Capital to Revenue	7.46%	17.28%	13.34%	3.10%	8.62%	0.00%
Debt-free Net Working Capital to Revenue	25.88%	27.83%	16.94%	11.29%	13.77%	0.00%
Net Working Capital to Revenue	23.20%	25.19%	13.15%	6.63%	4.56%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.22)	$1.03	$1.21	$0.91	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	44.01M	18.66M	15.37M	14.93M	0.00	0.00
Adjusted Diluted Earnings per Share	($1.22)	$0.96	$1.13	$0.14	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	44.01M	35.31M	32.56M	94.93M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	102.31M	80.53M	77.88M	76.07M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	75	114	111	57	59	61
Normalized NOPAT Margin	17.91%	29.30%	29.39%	21.27%	22.55%	25.01%
Pre Tax Income Margin	-19.25%	29.97%	35.98%	30.81%	29.86%	33.49%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-3.21	5.07	7.31	0.00	0.00	0.00
NOPAT to Interest Expense	3.71	4.16	5.20	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-3.63	4.68	6.89	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	3.29	3.76	4.78	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	-71.38%	34.09%	27.53%	288.48%	278.44%	127.41%
Augmented Payout Ratio	-71.38%	34.09%	27.53%	288.48%	278.44%	127.41%

This table displays calculated financial ratios and metrics derived from CompoSecure's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.96%	10.58%	10.19%	9.12%	6.52%	-6.21%	1.37%	13.22%	24.55%	56.09%
EBITDA Growth	-203.03%	-262.55%	1.16%	34.55%	36.82%	57.04%	-41.72%	-48.20%	25.89%	24.42%
EBIT Growth	-215.25%	-278.01%	0.13%	40.60%	40.51%	62.02%	-42.62%	-51.54%	32.14%	30.17%
NOPAT Growth	-59.73%	-27.53%	7.04%	-1.77%	12.15%	11.55%	-10.41%	13.41%	151.59%	16.64%
Net Income Growth	-255.87%	-324.64%	2.71%	59.01%	38.78%	73.79%	-46.07%	-60.10%	11.67%	17.12%
EPS Growth	-377.27%	-423.53%	10.34%	54.55%	10.00%	88.89%	-44.23%	-52.17%	66.67%	0.00%
Operating Cash Flow Growth	33.99%	13.01%	14.83%	35.56%	144.25%	-18.55%	-28.87%	109.06%	-63.60%	46.69%
Free Cash Flow Firm Growth	888.57%	579.24%	100.43%	71.13%	76.89%	-112.26%	-98.03%	-103.47%	0.00%	0.00%
Invested Capital Growth	-122.34%	-114.46%	40.73%	78.90%	82.80%	187.70%	77.10%	1,406.57%	224.46%	-85.62%
Revenue Q/Q Growth	-5.86%	-1.32%	4.38%	4.11%	3.11%	-1.67%	3.37%	1.63%	-9.21%	6.28%
EBITDA Q/Q Growth	42.65%	-283.74%	72.88%	-43.44%	-9.52%	14.35%	129.94%	-42.49%	3.85%	-57.56%
EBIT Q/Q Growth	41.47%	-303.11%	80.88%	-46.40%	-9.60%	14.24%	153.99%	-46.44%	4.24%	-59.54%
NOPAT Q/Q Growth	-46.37%	-35.46%	-3.63%	20.73%	-3.50%	-4.66%	-11.57%	37.85%	-4.01%	-23.43%
Net Income Q/Q Growth	43.42%	-354.41%	96.78%	-44.97%	-18.46%	16.32%	204.65%	-51.97%	2.11%	-63.91%
EPS Q/Q Growth	44.55%	-443.75%	88.24%	-22.73%	-35.29%	17.24%	163.64%	-45.00%	11.11%	-65.38%
Operating Cash Flow Q/Q Growth	25.88%	-12.75%	-4.45%	27.69%	6.17%	-11.34%	12.80%	130.06%	-64.60%	-22.57%
Free Cash Flow Firm Q/Q Growth	16.48%	1,374.81%	414.04%	76.30%	29.21%	-716.79%	145.23%	88.30%	-137.56%	-0.70%
Invested Capital Q/Q Growth	-88.97%	-113.59%	4.58%	-11.03%	22.36%	32.21%	32.94%	-15.00%	92.57%	-18.61%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	52.09%	51.72%	51.65%	53.08%	52.95%	50.47%	54.74%	55.98%	53.60%	59.78%
EBITDA Margin	-43.75%	-71.82%	38.57%	23.29%	42.87%	48.86%	42.01%	18.89%	33.37%	29.18%
Operating Margin	15.47%	27.15%	29.28%	29.94%	30.56%	29.73%	30.80%	30.86%	26.50%	24.82%
EBIT Margin	-46.17%	-74.26%	36.08%	20.82%	40.45%	46.13%	39.71%	16.16%	30.66%	26.70%
Profit (Net Income) Margin	-47.95%	-79.78%	30.95%	16.41%	31.06%	39.27%	33.20%	11.26%	23.84%	21.19%
Tax Burden Percent	104.62%	100.74%	99.24%	105.15%	88.83%	97.57%	97.12%	113.33%	97.29%	98.24%
Interest Burden Percent	99.26%	106.64%	86.43%	74.98%	86.43%	87.26%	86.09%	61.51%	79.90%	80.79%
Effective Tax Rate	0.00%	0.00%	0.76%	-5.15%	11.17%	2.43%	2.88%	-13.33%	2.71%	1.76%
Return on Invested Capital (ROIC)	122.53%	238.43%	167.06%	202.54%	143.23%	211.60%	252.68%	574.15%	1,896.28%	81.19%
ROIC Less NNEP Spread (ROIC-NNEP)	94.54%	202.59%	167.71%	197.42%	144.44%	214.58%	253.60%	567.84%	1,895.76%	79.32%
Return on Net Nonoperating Assets (RNNOA)	-114.67%	-228.47%	-217.37%	-247.58%	-187.41%	-254.70%	-292.28%	-608.19%	-1,923.65%	-205.63%
Return on Equity (ROE)	7.87%	9.96%	-50.31%	-45.05%	-44.17%	-43.10%	-39.60%	-34.04%	-27.37%	-124.44%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	131.93%	130.26%	96.04%	115.74%	180.61%	296.27%	32.08%	0.00%
Operating Return on Assets (OROA)	-57.54%	-98.85%	74.89%	41.64%	86.81%	97.24%	93.25%	38.24%	78.86%	47.32%
Return on Assets (ROA)	-59.75%	-106.19%	64.24%	32.83%	66.66%	82.78%	77.97%	26.66%	61.31%	37.55%
Return on Common Equity (ROCE)	21.31%	21.29%	-166.74%	-155.06%	-150.38%	-134.81%	-118.11%	-95.46%	-74.65%	-893.37%
Return on Equity Simple (ROE_SIMPLE)	0.00%	1.33%	-16.50%	-14.97%	0.00%	-12.43%	-10.10%	-13.03%	0.00%	-13.96%
Net Operating Profit after Tax (NOPAT)	11	20	32	33	27	28	29	33	24	25
NOPAT Margin	10.83%	19.01%	29.06%	31.48%	27.15%	29.00%	29.92%	34.97%	25.78%	24.38%
Net Nonoperating Expense Percent (NNEP)	27.99%	35.83%	-0.66%	5.11%	-1.21%	-2.97%	-0.92%	6.32%	0.51%	1.87%
Return On Investment Capital (ROIC_SIMPLE)	19.47%	-	-	-	-5.90%	-	-	-	-4.53%	-
Cost of Revenue to Revenue	47.91%	48.28%	48.35%	46.92%	47.05%	49.53%	45.26%	44.02%	46.40%	40.22%
SG&A Expenses to Revenue	36.62%	24.56%	22.36%	23.15%	22.39%	20.74%	23.94%	25.12%	27.11%	34.96%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	36.62%	24.56%	22.36%	23.15%	22.39%	20.74%	23.94%	25.12%	27.11%	34.96%
Earnings before Interest and Taxes (EBIT)	-47	-80	39	22	40	45	39	15	29	28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-44	-77	42	24	43	47	41	18	31	30
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.55	2.74	1.34	1.39	0.83	1.27	1.31	1.40	0.75	1.01
Price to Earnings (P/E)	0.00	0.00	20.84	26.55	16.90	24.93	34.56	31.11	15.25	0.00
Dividend Yield	2.46%	2.14%	4.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	4.80%	3.77%	5.92%	4.01%	2.89%	3.21%	6.56%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	16.30	17.95	12.78	17.90	24.36	33.24	23.48	48.51
Enterprise Value to Revenue (EV/Rev)	2.84	3.39	3.31	3.58	3.13	3.64	3.69	3.80	3.25	3.66
Enterprise Value to EBITDA (EV/EBITDA)	0.00	44.46	8.68	9.18	8.18	10.14	11.93	9.83	7.35	8.20
Enterprise Value to EBIT (EV/EBIT)	0.00	65.62	9.30	9.80	8.76	10.94	13.00	10.57	7.86	8.83
Enterprise Value to NOPAT (EV/NOPAT)	15.88	0.00	11.49	12.33	10.69	12.50	13.18	13.23	11.05	13.59
Enterprise Value to Operating Cash Flow (EV/OCF)	9.23	11.79	11.56	12.63	11.73	15.79	15.27	13.99	13.25	11.81
Enterprise Value to Free Cash Flow (EV/FCFF)	6.22	0.00	14.44	17.68	17.20	22.95	17.24	21.05	73.19	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-1.39	-1.15	-1.57	-1.68	-1.67	-1.43	-1.30	-1.23	-1.23	-1.13
Long-Term Debt to Equity	-1.31	-1.11	-1.50	-1.62	-1.62	-1.38	-1.23	-1.17	-1.18	-1.10
Financial Leverage	-1.21	-1.13	-1.30	-1.25	-1.30	-1.19	-1.15	-1.07	-1.01	-2.59
Leverage Ratio	-1.93	-1.20	-0.82	-0.82	-0.73	-0.65	-0.55	-0.49	-0.42	-2.99
Compound Leverage Factor	-1.92	-1.28	-0.71	-0.61	-0.63	-0.56	-0.47	-0.30	-0.34	-2.42
Debt to Total Capital	355.78%	789.09%	276.24%	246.46%	250.28%	334.07%	432.49%	534.11%	542.43%	862.19%
Short-Term Debt to Total Capital	20.06%	24.18%	11.32%	8.81%	7.53%	10.13%	22.93%	27.96%	21.78%	22.73%
Long-Term Debt to Total Capital	335.72%	764.92%	264.92%	237.65%	242.75%	323.95%	409.56%	506.15%	520.66%	839.47%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	435.29%	442.70%	435.71%	584.68%	729.53%	889.50%	909.47%	1,414.52%
Common Equity to Total Capital	-255.78%	-689.09%	-611.54%	-589.16%	-585.99%	-818.75%	-1,062.02%	-1,323.61%	-1,351.91%	-2,176.71%
Debt to EBITDA	-3.63	10.20	2.10	2.13	2.29	2.47	2.93	2.38	2.14	2.29
Net Debt to EBITDA	-2.22	8.56	1.87	1.78	2.02	2.30	2.74	2.23	2.06	2.19
Long-Term Debt to EBITDA	-3.43	9.89	2.01	2.06	2.22	2.39	2.77	2.26	2.05	2.23
Debt to NOPAT	2.65	-0.12	2.78	2.86	2.99	3.04	3.23	3.20	3.22	3.78
Net Debt to NOPAT	1.62	-0.10	2.48	2.39	2.63	2.83	3.03	3.00	3.10	3.63
Long-Term Debt to NOPAT	2.50	-0.12	2.66	2.76	2.90	2.95	3.06	3.04	3.09	3.69
Altman Z-Score	0.36	0.07	-1.24	-1.88	-2.22	-2.44	-3.05	-3.50	-4.30	-4.54
Noncontrolling Interest Sharing Ratio	-170.83%	-113.88%	-231.40%	-244.24%	-240.44%	-212.79%	-198.25%	-180.44%	-172.74%	-617.92%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.28	2.43	2.79	3.56	3.40	2.43	2.21	1.98	2.05	1.54
Quick Ratio	1.64	1.49	1.53	2.13	1.99	1.37	1.16	1.04	1.08	0.91
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	128	110	7.45	-2.37	-16	-23	3.72	-8.22	-70	187
Operating Cash Flow to CapEx	1,207.12%	1,418.15%	1,684.90%	2,092.44%	618.32%	2,561.52%	1,382.77%	679.13%	590.72%	822.44%
Free Cash Flow to Firm to Interest Expense	0.00	742.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	190.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	176.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.25	1.33	2.08	2.00	2.15	2.11	2.35	2.37	2.57	1.77
Accounts Receivable Turnover	9.57	9.09	10.75	10.75	10.05	8.15	9.57	10.02	11.61	0.00
Inventory Turnover	4.14	3.74	3.69	3.54	3.83	3.91	4.42	4.21	4.66	0.00
Fixed Asset Turnover	17.29	18.19	17.08	16.34	16.32	16.76	17.26	17.12	16.88	0.00
Accounts Payable Turnover	24.06	16.84	24.44	18.61	29.47	13.34	25.44	16.29	22.39	20.05
Days Sales Outstanding (DSO)	38.16	40.16	33.96	33.96	36.33	44.77	38.16	36.43	31.44	0.00
Days Inventory Outstanding (DIO)	88.26	97.70	98.93	103.15	95.41	93.39	82.56	86.60	78.34	0.00
Days Payable Outstanding (DPO)	15.17	21.68	14.94	19.61	12.38	27.36	14.35	22.41	16.30	18.20
Cash Conversion Cycle (CCC)	111.25	116.18	117.95	117.49	119.36	110.80	106.37	100.62	93.48	-18.20
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-21	-11	83	80	96	78	59	45	52	27
Invested Capital Turnover	11.32	12.54	5.75	6.43	5.28	7.30	8.45	16.42	73.55	3.33
Increase / (Decrease) in Invested Capital	-117	-90	24	35	43	51	26	42	94	-162
Enterprise Value (EV)	1,196	1,422	1,357	1,429	1,223	1,400	1,441	1,480	1,229	1,319
Market Capitalization	1,074	1,148	548	556	325	487	513	547	285	364
Book Value per Share	($1.63)	($3.48)	($9.00)	($9.86)	($10.12)	($10.57)	($11.08)	($11.40)	($11.69)	($12.19)
Tangible Book Value per Share	($1.63)	($3.48)	($9.00)	($9.86)	($10.12)	($10.57)	($11.08)	($11.40)	($11.69)	($12.19)
Total Capital	56	41	119	135	137	102	82	67	66	43
Total Debt	200	326	328	332	343	341	354	358	358	367
Total Long-Term Debt	188	316	314	320	332	331	335	339	344	358
Net Debt	122	274	292	277	301	317	331	336	344	352
Capital Expenditures (CapEx)	2.93	1.98	1.91	1.61	4.28	0.97	2.03	3.67	1.83	3.72
Debt-free, Cash-free Net Working Capital (DFCFNWC)	31	50	66	65	68	62	57	54	50	30
Debt-free Net Working Capital (DFNWC)	109	102	101	120	109	86	80	77	64	46
Net Working Capital (NWC)	98	92	87	108	98	75	61	58	50	36
Net Nonoperating Expense (NNE)	59	106	-2.05	16	-3.91	-9.95	-3.24	23	1.82	3.30
Net Nonoperating Obligations (NNO)	122	274	292	277	301	317	331	336	344	352
Total Depreciation and Amortization (D&A)	2.44	2.62	2.70	2.57	2.42	2.64	2.27	2.60	2.55	2.56
Debt-free, Cash-free Net Working Capital to Revenue	7.46%	11.81%	16.01%	16.30%	17.28%	16.10%	14.69%	13.94%	13.34%	8.47%
Debt-free Net Working Capital to Revenue	25.88%	24.36%	24.66%	30.11%	27.83%	22.29%	20.47%	19.73%	16.94%	12.76%
Net Working Capital to Revenue	23.20%	21.98%	21.37%	27.13%	25.19%	19.60%	15.68%	14.92%	13.15%	10.07%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.76)	($1.10)	$0.44	$0.20	$0.20	$0.39	$0.31	$0.13	$0.24	$0.18
Adjusted Weighted Average Basic Shares Outstanding	44.01M	38.21M	25.44M	20.57M	18.66M	19.07M	18.54M	17.63M	15.37M	15.43M
Adjusted Diluted Earnings per Share	($0.61)	($1.10)	$0.32	$0.17	$0.22	$0.34	$0.29	$0.11	$0.20	$0.18
Adjusted Weighted Average Diluted Shares Outstanding	44.01M	38.21M	96.64M	96.24M	35.31M	35.76M	35.53M	94.74M	32.56M	19.66M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	102.31M	88.13M	81.91M	80.59M	80.53M	79.32M	79.00M	78.39M	77.88M	76.35M
Normalized Net Operating Profit after Tax (NOPAT)	11	20	32	22	27	28	29	21	24	25
Normalized NOPAT Margin	10.83%	19.01%	29.06%	20.95%	27.15%	29.00%	29.92%	21.60%	25.78%	24.38%
Pre Tax Income Margin	-45.83%	-79.19%	31.18%	15.61%	34.96%	40.25%	34.18%	9.94%	24.50%	21.57%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	-537.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	137.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	-550.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	124.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-71.38%	-1,570.32%	37.12%	32.64%	34.09%	37.66%	45.12%	39.78%	27.53%	196.05%
Augmented Payout Ratio	-71.38%	-1,570.32%	37.12%	32.64%	34.09%	37.66%	45.12%	39.78%	27.53%	196.05%

Frequently Asked Questions About CompoSecure's Financials

When does CompoSecure's financial year end?

According to the most recent income statement we have on file, CompoSecure's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CompoSecure's net income changed over the last 5 years?

CompoSecure's net income appears to be on a downward trend, with a most recent value of -$83.16 million in 2024, falling from $81.47 million in 2019. The previous period was $112.52 million in 2023. See where experts think CompoSecure is headed by visiting CompoSecure's forecast page.

What is CompoSecure's operating income?

CompoSecure's total operating income in 2024 was $107.62 million, based on the following breakdown:

Total Gross Profit: $219.23 million
Total Operating Expenses: $111.61 million

How has CompoSecure revenue changed over the last 5 years?

Over the last 5 years, CompoSecure's total revenue changed from $243.29 million in 2019 to $420.57 million in 2024, a change of 72.9%.

How much debt does CompoSecure have?

CompoSecure's total liabilities were at $617.36 million at the end of 2024, a 51.8% increase from 2023, and a 125.4% increase since 2020.

How much cash does CompoSecure have?

In the past 4 years, CompoSecure's cash and equivalents has ranged from $13.42 million in 2020 to $77.46 million in 2024, and is currently $77.46 million as of their latest financial filing in 2024.

How has CompoSecure's book value per share changed over the last 5 years?

Over the last 5 years, CompoSecure's book value per share changed from 0.00 in 2019 to -1.63 in 2024, a change of -162.8%.

Related Companies

This page (NASDAQ:CMPO) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CompoSecure (CMPO) Financials

Frequently Asked Questions About CompoSecure's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CompoSecure (CMPO) Financials

Annual Income Statements for CompoSecure

Quarterly Income Statements for CompoSecure

Annual Cash Flow Statements for CompoSecure

Quarterly Cash Flow Statements for CompoSecure

Annual Balance Sheets for CompoSecure

Quarterly Balance Sheets for CompoSecure

Annual Metrics And Ratios for CompoSecure

Quarterly Metrics And Ratios for CompoSecure

Frequently Asked Questions About CompoSecure's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools